NASDAQ:DBVT
DBV Technologies S.A. Stock News
$0.571
-0.123 (-17.77%)
At Close: May 09, 2024
The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance
02:26pm, Thursday, 30'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 29) 10X Genomics Inc (NASDAQ: TXG ) Agile Therapeutics
DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares For $125M Worth of Company's ADS
12:00am, Wednesday, 29'th Jan 202020 Biotechnology Stocks Moving In Tuesday's After-Market Session
12:00am, Tuesday, 21'st Jan 2020
Rafaèle Tordjman launches JEITO CAPITAL, a new French and independent investment investor dedicated to biotech and biopharma. The launch is completed by the closing of JEITO I fund's with the support
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
12:00am, Wednesday, 15'th Jan 2020Apellis Pharmaceuticals Phase 3 Success, And Other News: The Good, Bad, And Ugly Of Biopharma
03:27pm, Friday, 10'th Jan 2020
Apellis Pharmaceuticals' PEGASUS trial produced positive data. DBV Technologies saw success in a peanut allergy trial. Mylan recalled some bad medicine.
The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx
12:13pm, Friday, 10'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 9) Acceleron Pharma Inc (NASDAQ: XLRN ) Allergan plc (
21 Healthcare Stocks Moving In Friday's Pre-Market Session
12:00am, Friday, 10'th Jan 2020
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 8.) Allergan plc (NYSE: AGN ): AbbVie Inc (
UBS upgrades Madrigal Pharma in premarket analyst action
01:10pm, Thursday, 09'th Jan 2020
Aptose Biosciences (APS CN) initiated with Overweight rating at Piper Sandler. Shares up 2% premarket in U.S. (NASDAQ:APTO).BioDelivery Sciences (NASDAQ:BDSI) initiated with Overweight rating and $9
